EUVIMEDEUVIMED entdecken
Open Access

Electronic Health Record-Based Estimates of Acute Disseminated Encephalomyelitis Epidemiology in a Large Healthcare Network, 2000-2025

Alexandra Balshi iD, John P Dempsey, Yanli Zhang-James, Jacob A Sloane

The Neurohospitalist · 18.06.2026

DOI: 10.1177/19418744261463751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Neurohospitalist, online erschienen am 18.06.2026. Verfasst von Alexandra Balshi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute disseminated encephalomyelitis (ADEM) is a rare, rapidly progressive, immune-mediated demyelinating disorder with limited contemporary data describing its epidemiology in adults and real-world uptake of myelin oligodendrocyte glycoprotein (MOG) autoantibody testing.

Methods

We used the TriNetX global collaborative network (112 contributing healthcare organizations) to estimate ADEM prevalence and incidence rates from 2000 to 2025, both overall and stratified by age of onset, sex, race, and ethnicity. We also assessed uptake of MOG autoantibody testing among people with an ADEM diagnosis code.

Results

We identified 4911 ADEM cases among 153,342,461 individuals from 2000 to 2025. Overall period prevalence was 3.26 (95% CI [confidence interval] 3.17-3.35) per 100,000 persons and overall incidence rate was 0.63 per 100,000 person-years (95% CI: 0.61-0.65). ADEM diagnosis codes were most frequently recorded in those ≤14 years old. Estimated were similar between sexes, lower among Black compared to White individuals, but similar across other racial groups and ethnicities. Only 11% of ADEM-coded individuals had documented MOG autoantibody testing.

Conclusion

In a large, real-world, electronic health record network, ADEM diagnosis codes were most frequently recorded in children, though cases were observed across the adult age range. MOG autoantibody testing was uncommon.

Schlagwörter

Stichwörter der Autor:innen

acute disseminatedautoimmune diseases of the nervous systemdemyelinating diseasesencephalomyelitis

Autor:innen und Institutionen

  • Harvard Medical School, Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Norton College of Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.

ORCID-Profile: Alexandra Balshi

Zitieren

APA

Balshi, A., Dempsey, J. P., Zhang-James, Y., & Sloane, J. A. (2026). Electronic Health Record-Based Estimates of Acute Disseminated Encephalomyelitis Epidemiology in a Large Healthcare Network, 2000-2025. The Neurohospitalist. https://doi.org/10.1177/19418744261463751

Vancouver

Balshi A, Dempsey JP, Zhang-James Y, Sloane JA. Electronic Health Record-Based Estimates of Acute Disseminated Encephalomyelitis Epidemiology in a Large Healthcare Network, 2000-2025. The Neurohospitalist. 2026. doi:10.1177/19418744261463751

BibTeX
@article{Balshi2026,
  author = {Balshi, Alexandra and Dempsey, John P and Zhang-James, Yanli and Sloane, Jacob A},
  title = {Electronic Health Record-Based Estimates of Acute Disseminated Encephalomyelitis Epidemiology in a Large Healthcare Network, 2000-2025},
  journal = {The Neurohospitalist},
  year = {2026},
  doi = {10.1177/19418744261463751}
}
Kostenlos starten →